Discover how the calprotectin test helps Uzbekistan improve gastrointestinal disease diagnosis with a fast, non-invasive, and reliable solution.

WIZBIOTECH presented innovative fecal calprotectin and dual stool testing solutions at the 2025 China Geriatric Laboratory Medicine Conference, focusing on elderly gut health and colorectal cancer screening.

Discover how the fecal calprotectin test helps differentiate IBS from IBD, monitor inflammatory bowel disease, and support early colorectal cancer detection—all through a simple, non-invasive stool test.

Wizbiotech highlighted the WIZ-A101 convenient immunoanalyzer, infectious disease quadriplex and bowel cancer early screening solutions, which attracted a large number of international professional visitors and received good feedback and business negotiations.

Colorectal cancer is one of the most common malignant tumors and its incidence is increasing year by year. Early detection of colorectal cancer is crucial for treatment and prognosis, so screening has become one of the important means to prevent colorectal cancer. At present, the commonly used colorectal cancer screening methods include colonoscopy, stool occult blood test and so on.

Colorectal cancer is one of the most common malignant tumors of the digestive system worldwide, and early diagnosis and treatment are essential to improve the survival rate of patients.